Integrated Proteins Ltd
Incorporated in 1992, Integrated Proteins Ltd is in the business of trading in various oil seeds and agri commodities.[1]
- Market Cap ₹ 17.2 Cr.
- Current Price ₹ 46.9
- High / Low ₹ 78.3 / 31.2
- Stock P/E 68.9
- Book Value ₹ 54.8
- Dividend Yield 0.00 %
- ROCE 2.40 %
- ROE 2.20 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.86 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 13.0%
- Company has a low return on equity of 1.83% over last 3 years.
- Promoter holding has decreased over last 3 years: -33.2%
- Working capital days have increased from 64.2 days to 339 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.07 | 0.09 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.24 | 21.50 | 21.50 | |
0.12 | 0.14 | 0.15 | 0.09 | 0.09 | 0.14 | 0.11 | 0.10 | 0.08 | 0.26 | 0.36 | 21.41 | 21.43 | |
Operating Profit | -0.05 | -0.05 | -0.07 | -0.09 | -0.09 | -0.14 | -0.11 | -0.10 | -0.08 | -0.09 | -0.12 | 0.09 | 0.07 |
OPM % | -71.43% | -55.56% | -87.50% | -52.94% | -50.00% | 0.42% | 0.33% | ||||||
0.19 | 0.17 | 0.18 | 0.20 | 0.18 | 0.17 | 0.16 | 0.16 | 0.16 | 0.16 | 0.25 | 0.24 | 0.25 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 |
Profit before tax | 0.11 | 0.09 | 0.08 | 0.08 | 0.06 | 0.00 | 0.02 | 0.03 | 0.05 | 0.04 | 0.10 | 0.32 | 0.32 |
Tax % | 0.00% | 0.00% | 0.00% | 50.00% | 83.33% | 50.00% | 33.33% | 40.00% | 25.00% | 10.00% | 21.88% | ||
0.11 | 0.09 | 0.08 | 0.05 | 0.01 | 0.02 | 0.01 | 0.02 | 0.04 | 0.03 | 0.09 | 0.25 | 0.25 | |
EPS in Rs | 0.30 | 0.24 | 0.22 | 0.14 | 0.03 | 0.05 | 0.03 | 0.05 | 0.11 | 0.08 | 0.24 | 0.68 | 0.68 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 73% |
5 Years: | % |
3 Years: | % |
TTM: | 8858% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 90% |
3 Years: | 84% |
TTM: | 127% |
Stock Price CAGR | |
---|---|
10 Years: | 35% |
5 Years: | 78% |
3 Years: | 56% |
1 Year: | 27% |
Return on Equity | |
---|---|
10 Years: | 2% |
5 Years: | 2% |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 |
Reserves | -1.20 | -1.12 | -1.03 | -0.98 | -0.98 | -1.09 | -1.09 | -1.07 | -1.03 | -1.00 | -0.91 | 16.60 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.08 | 0.19 | 0.04 | 3.90 | |
0.16 | 0.16 | 0.18 | 0.05 | 0.10 | 0.13 | 0.12 | 0.13 | 0.12 | 0.10 | 0.08 | 8.35 | |
Total Liabilities | 2.48 | 2.56 | 2.67 | 2.59 | 2.64 | 2.56 | 2.55 | 2.61 | 2.69 | 2.81 | 2.73 | 32.37 |
0.67 | 0.64 | 0.61 | 0.58 | 0.55 | 0.52 | 0.49 | 0.47 | 0.44 | 0.41 | 0.42 | 0.05 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.10 | 0.10 | 0.15 | 0.00 |
1.80 | 1.91 | 2.06 | 2.01 | 2.09 | 2.04 | 2.06 | 2.03 | 2.15 | 2.30 | 2.16 | 32.32 | |
Total Assets | 2.48 | 2.56 | 2.67 | 2.59 | 2.64 | 2.56 | 2.55 | 2.61 | 2.69 | 2.81 | 2.73 | 32.37 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.08 | -0.07 | -0.08 | -0.21 | -0.24 | 0.14 | -0.16 | -0.09 | -0.09 | -0.12 | -0.06 | -22.15 | |
-0.30 | 0.08 | 0.18 | 0.18 | 0.18 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 | 0.15 | 1.06 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 | 0.03 | 0.05 | 0.11 | -0.16 | 21.12 | |
Net Cash Flow | -0.22 | 0.01 | 0.10 | -0.02 | -0.07 | 0.08 | -0.13 | -0.03 | -0.04 | -0.01 | -0.07 | 0.03 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 52.14 | 0.00 | 136.88 | 0.00 | 0.00 | 0.00 | ||||||
Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 52.14 | 0.00 | 136.88 | 0.00 | 0.00 | 0.00 | ||||||
Working Capital Days | -834.29 | -608.33 | -730.00 | -85.88 | -60.83 | 339.20 | ||||||
ROCE % | 4.52% | 3.81% | 3.27% | 3.18% | 2.36% | 0.00% | 0.82% | 1.22% | 1.98% | 1.52% | 0.37% | 2.40% |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30, 32 And 33 Of The SEBI
(LODR) Regulations, 2015, As Amended ('SEBI LODR").
1d - Integrated Proteins reports Q1 FY26 unaudited results; marginal profit Rs.0.01 lakh; no fund usage deviation.
-
Board Meeting Intimation for Prior Intimation Of Board Meeting And Trading Window Regulation 29 (1)(A) Of The SEBI (LODR) Regulation, 2015
8 Aug - Board meeting on 14 Aug to approve Q1 June 2025 results; trading window reopens 16 Aug.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 8 Aug
-
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
8 Aug - Vedankit Traders acquires 5.34% stake in Integrated Proteins via preferential allotment on 07-08-2025.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 8 Aug
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
IPL is engaged in the business of manufacturing, trading, and processing various oilseeds. There was an operational shift in the business as:
a) The company ceased operations in the solvent extraction of oilseeds.
b) In FY24, the company explored one of its main objectives and commenced trading in agri
commodities.